The impact of the apparent diffusion coefficient for the early prediction of the treatment response after definitive radiotherapy in prostate cancer patients-Reference-Cited by-同舟云学术

The impact of the apparent diffusion coefficient for the early prediction of the treatment response after definitive radiotherapy in prostate cancer patients

Published:2023-07 Issue: Volume:184 Page:109677
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Onal Cem,Erbay Gurcan,Oymak Ezgi,Guler Ozan Cem

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference44 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries;Sung;CA Cancer J Clin,2021

2. External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study;Bolla;Lancet Oncol,2010

3. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma–long-term results of phase III RTOG 85–31;Pilepich;Int J Radiat Oncol Biol Phys,2005

4. Limitations in the use of serum prostate specific antigen levels to monitor patients after treatment for prostate cancer;Vicini;J Urol,2005

5. Prognostic significance of the nadir prostate specific antigen level after hormone therapy for prostate cancer;Kwak;J Urol,2002

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of definitive radiotherapy on metabolic response measured with ⁶⁸Ga‐PSMA‐PET/CT in patients with intermediate‐risk prostate cancer;The Prostate;2024-08-06

2. Comprehensive diagnostic model of metastasis in prostate cancer: Individual and combined bioscore model of ADC value, Gleason score, and PSA;Precision Medical Sciences;2024-06-29

3. Biomarker-driven molecular imaging probes in radiotherapy;Theranostics;2024

4. Identifying patients suitable for targeted adjuvant therapy: advances in the field of developing biomarkers for tumor recurrence following irradiation;Expert Review of Precision Medicine and Drug Development;2023-11-16